Neuphoria Therapeutics Inc. (NEUP) stock
NEUPNasdaqPharmaceutical PreparationsFiscal year ends June 30
$2.55−0.03 (-1.16%)
Close on Nov 13, 2026Market cap $76.66KP/E –Yield –
Neuphoria Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2026 it was -1401.1%, against -7.2% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -1401.1% | −1393.9 |
| FY2025 | Jun 30, 2025 | -7.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | 79.8% | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -558.8% | – |
See a number that looks wrong?